Personal data is processed exclusively within the framework of the Data Controller, specifically for the following purposes: 5
The key finding of much less weight loss in the new trial with Type 2 diabetes helps us understand the story of GLP-1s success its not just because of reduced body weight
If youre not eating enough, milk supply can drop, putting your baby at risk
Expert Commentary The rise of GLP-1 receptor agonists like semaglutide and tirzepatide reflects a major shift in how we approach both type 2 diabetes and obesity
Plaintiffs have raised concerns that severe side effects, including stomach paralysis, were not adequately disclosed, thereby affecting patient health adversely
That usually means combining your medication plan with strength training, enough protein, daily movement, recovery, and carbohydrate intake that matches your activity level